Literature DB >> 25841552

Anaphylaxis to insect stings.

David B K Golden1.   

Abstract

Anaphylaxis to insect stings has occurred in 3% of adults and can be fatal even on the first reaction. Large local reactions are more frequent but rarely dangerous. The chance of a systemic reaction to a sting is 5% to 10% in large local reactors and in children with mild (cutaneous) systemic reactions, and varies between 30% and 65% in adults with previous systemic reactions, depending on the severity of previous sting reactions. Baseline serum tryptase level is increased in many patients with sting anaphylaxis. Venom immunotherapy is 75% to 98% effective in preventing sting anaphylaxis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Diagnostic tests; Hymenoptera; Immunotherapy; Insect sting; Mastocytosis; Venom

Mesh:

Substances:

Year:  2015        PMID: 25841552     DOI: 10.1016/j.iac.2015.01.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  16 in total

Review 1.  Component Resolved Diagnosis in Hymenoptera Anaphylaxis.

Authors:  D Tomsitz; K Brockow
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.806

2.  Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy.

Authors:  L Ricciardi
Journal:  Int J Immunopathol Pharmacol       Date:  2016-09-27       Impact factor: 3.219

3.  Pre-hospital treatment of bee and wasp induced anaphylactic reactions: a retrospective study.

Authors:  Athamaica Ruiz Oropeza; Søren Mikkelsen; Carsten Bindslev-Jensen; Charlotte G Mortz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-01-14       Impact factor: 2.953

4.  Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study.

Authors:  Eleonora Savi; Cristoforo Incorvaia; Elisa Boni; Marina Mauro; Silvia Peveri; Valerio Pravettoni; Oliviero Quercia; Federico Reccardini; Marcello Montagni; Laura Pessina; Erminia Ridolo
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

Review 5.  Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence.

Authors:  Irene Martignago; Cristoforo Incorvaia; Erminia Ridolo
Journal:  Clin Mol Allergy       Date:  2017-06-15

6.  Hymenoptera sting reactions in southern Italy forestry workers: our experience compared to reported data.

Authors:  Luisa Ricciardi; Francesco Papia; Giuseppe Cataldo; Mario Giorgianni; Giovanna Spatari; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2018-04-17

Review 7.  Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.

Authors:  Maximilian Schiener; Anke Graessel; Markus Ollert; Carsten B Schmidt-Weber; Simon Blank
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

8.  Functional Profile of Antigen Specific CD4+ T Cells in the Immune Response to Phospholipase A1 Allergen from Polybia paulista Venom.

Authors:  Luís Gustavo Romani Fernandes; Amilcar Perez-Riverol; Murilo Luiz Bazon; Débora Moitinho Abram; Márcia Regina Brochetto-Braga; Ricardo de Lima Zollner
Journal:  Toxins (Basel)       Date:  2020-06-08       Impact factor: 4.546

9.  Allergen immunotherapy for insect venom allergy: protocol for a systematic review.

Authors:  Sangeeta Dhami; Ulugbek Nurmatov; Eva-Maria Varga; Gunter Sturm; Antonella Muraro; Cezmi A Akdis; Darío Antolín-Amérigo; M Beatrice Bilò; Danijela Bokanovic; Moises A Calderon; Ewa Cichocka-Jarosz; Joanna N G Oude Elberink; Radoslaw Gawlik; Thilo Jakob; Mitja Kosnik; Joanna Lange; Ervin Mingomataj; Dimitris I Mitsias; Holger Mosbech; Oliver Pfaar; Constantinos Pitsios; Valerio Pravettoni; Graham Roberts; Franziska Ruëff; Betül Ayşe Sin; Aziz Sheikh
Journal:  Clin Transl Allergy       Date:  2016-02-16       Impact factor: 5.871

Review 10.  Fatal Anaphylaxis: Mortality Rate and Risk Factors.

Authors:  Paul J Turner; Elina Jerschow; Thisanayagam Umasunthar; Robert Lin; Dianne E Campbell; Robert J Boyle
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Sep - Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.